K Number
K241642
Date Cleared
2024-08-02

(56 days)

Product Code
Regulation Number
878.4810
Reference & Predicate Devices
Predicate For
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The Diode Laser Hair Removal System (Model: MBT-Diode Laser) is intended for hair removal, permanent hair reduction on all skin types (Fitzpatrick skin type I-VI), including tanned skin. Permanent hair reduction is defined as the long-term. stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime.

Device Description

Diode Laser Hair Removal System (Model: MBT-Diode Laser) is a surgical device, which is intended for hair removal, permanent hair reduction on all skin types (Fitzpatrick skin type I-VI). The Dermatological Diode Laser Systems utilize a semiconductor diode with invisible infrared radiation as a laser source to emit 808nm wavelength laser which is absorbed by melanin. The laser power is delivered to the treatment area via laser handle. The emission laser is activated by footswitch or handle button.

The Diode Laser Hair Removal System consists of the following major components

  • The main console unit that incorporates the main CPU board, power supply modules, laser power supply, laser device, cooling system and switching module
  • Handpiece
  • Footswitch
AI/ML Overview

The provided text is a 510(k) Summary for a Diode Laser Hair Removal System (MBT-Diode Laser). It describes the device, its intended use, and a comparison to a predicate device to demonstrate substantial equivalence.

Here's an analysis of the acceptance criteria and study information, based on the provided text:

1. Table of Acceptance Criteria and Reported Device Performance

The submission does not outline specific, quantified acceptance criteria for the new device as would be seen in a clinical study. Instead, it demonstrates substantial equivalence to a predicate device by comparing technical specifications and adherence to recognized standards.

The table below summarizes the technical comparison provided, where "acceptance criteria" can be interpreted as demonstrating equivalence or justification for differences compared to the predicate/reference devices:

FeatureAcceptance Criteria (Comparison to Predicate/Reference)Reported Device Performance (Proposed Device)
General
Device NameNA (for comparison)Diode Laser Hair Removal System
Classification RegulationSAME as predicate (21 CFR 878.4810)21 CFR 878.4810
Classification PanelSAME as predicate (General & Plastic Surgery)General & Plastic Surgery
ClassSAME as predicate (II)II
Product CodeSAME as predicate (GEX)GEX
Indications for UseSAME as predicate: Hair removal, permanent hair reduction on all skin types (Fitzpatrick I-VI), including tanned skin. Permanent hair reduction defined as long-term, stable reduction measured at 6, 9, and 12 months post-treatment.Same as criterion
Performance (Technical)
Laser TypeSAME as predicate (Diode Laser)Diode Laser
Laser ClassificationSAME as predicate (Class IV)Class IV
Laser WavelengthSAME as predicate (808nm)808nm
Spot SizeSIMILAR to predicate (15mm x 15mm vs. 2.25cm², 1.44cm²)15mm x 15mm
FluenceDifferent from predicate (0-120 J/cm²), but justified as lower (55.96 J/cm²) and similar to reference device (48 J/cm²) for effectiveness. Safety ensured by compliance with standards.1-55.96 J/cm²
FrequencySAME as predicate (1-10Hz)1-10Hz
Pulse DurationDifferent from predicate (10-400ms), but within predicate range (2-240ms) and considered a minor difference not affecting effectiveness/safety. Safety ensured by compliance with standards.2-240ms
Power SupplyDifferent from predicate (220/110 VAC/50Hz-60Hz), but electrical safety and EMC tests conducted ensure normal operation.110 VAC/50Hz-60Hz
DimensionDifferent from predicate (112 cm x 42 cm x 60 cm), but mechanical performance accepted by IEC 60601-1.650mm x 580mm x 1210mm
WeightDifferent from predicate (63Kg), but mechanical performance accepted by IEC 60601-1.68Kg
Safety
Electrical SafetyComply with IEC 60601-1, IEC 60601-2-22 (SAME as predicate)Complies
EMCComply with IEC 60601-1-2 (SAME as predicate)Complies
Laser SafetyComply with IEC 60601-2-22, IEC 60825 (SAME as predicate)Complies
CytotoxicityNo Cytotoxicity (SAME as predicate; aligns with ISO 10993-5)No Cytotoxicity
SensitizationNo evidence of sensitization (SAME as predicate; aligns with ISO 10993-10)No evidence of sensitization
IrritationNo evidence of irritation (SAME as predicate; aligns with ISO 10993-23)No evidence of irritation

2. Sample Size Used for the Test Set and Data Provenance

The document explicitly states: "No clinical study is included in this submission."
Therefore, there is no "test set" in the context of clinical performance data. The evaluation relies on non-clinical (bench) testing and comparison to predicate devices, not human subject data.

Since no clinical study was conducted, there is no data provenance (country of origin, retrospective/prospective) for a test set.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

Not applicable. As no clinical study was conducted and no clinical test set was used, there was no ground truth for a test set established by experts.

4. Adjudication Method for the Test Set

Not applicable. As no clinical study was conducted and no clinical test set was used, there was no adjudication method.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done

No. The document explicitly states: "No clinical study is included in this submission." Therefore, no MRMC study was conducted.

6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done

The device is a hardware product (Diode Laser Hair Removal System), not an algorithm or software-only device. Therefore, the concept of "standalone algorithm performance" as typically applied to AI/software as a medical device (SaMD) is not applicable here. The performance is evaluated based on its physical/electrical characteristics and safety standards.

7. The Type of Ground Truth Used

For the non-clinical tests regarding electrical safety, EMC, laser safety, and biocompatibility, the "ground truth" is defined by compliance with internationally recognized standards (e.g., IEC 60601-1, IEC 60601-1-2, IEC 60825-1, IEC 60601-2-22, ISO 10993 series). The device's performance is measured against the requirements of these standards.

8. The Sample Size for the Training Set

Not applicable. This is a hardware device submission, not an AI/ML algorithm requiring a training set.

9. How the Ground Truth for the Training Set Was Established

Not applicable. No training set was used.

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo is in blue and includes the letters "FDA" followed by the words "U.S. Food & Drug Administration" in a larger font. The word "Administration" is written in a smaller font below the other words.

August 2, 2024

Beijing Mega Beautv Technology Co.,Ltd. % Ray Wang General Manager Beijing Believe-Med Technology Service Co., Ltd. Rm.912, Building #15, XiYueHui, No.5, YiHe North Rd., FangShan District Beijing, 102401 China

Re: K241642

Trade/Device Name: Diode Laser Hair Removal System (MBT-Diode Laser) Regulation Number: 21 CFR 878.4810 Regulation Name: Laser Surgical Instrument For Use In General And Plastic Surgery And In Dermatology Regulatory Class: Class II Product Code: GEX Dated: June 6, 2024 Received: June 7, 2024

Dear Ray Wang:

We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

{1}------------------------------------------------

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).

Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product: and 21 CFR 820.100. Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations. please see Device (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn).

{2}------------------------------------------------

Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/deviceadvice-comprehensive-regulatory-assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely.

TANISHA TANISHA L. HITHE -S L. HITHE -S Date: 2024.08.0

Tanisha Hithe Assistant Director DHT4A: Division of General Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{3}------------------------------------------------

Indications for Use

Form Approved: OMB No. 0910-0120 Expiration Date: 07/31/2026 See PRA Statement below.

Submission Number (if known)

K241642

Device Name

Diode Laser Hair Removal System (MBT-Diode Laser)

Indications for Use (Describe)

The Diode Laser Hair Removal System (Model: MBT-Diode Laser) is intended for hair removal, permanent hair reduction on all skin types (Fitzpatrick skin type I-VI), including tanned skin. Permanent hair reduction is defined as the long-term. stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime.

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{4}------------------------------------------------

K241642 510(k) Summary

This 510(k) Summary of 510(k) safety and effectiveness information is being submitted in accordance with requirements of SMDA 1990 and Title 21, CFR Section 807.92.

The assigned 510(k) Number: __________________________________________________________________________________________________________________________________________________

  • Date of Preparation:2024/06/06 1.
    1. Sponsor Identification

Beijing Mega Beauty Technology Co.,Ltd.

Room 1-524, Building No.4, Xinyuan Road No.27, Daxing District, Beijing, 102629 China.

Contact Person: Alex Yu Position: General Manager Tel: +86 13581869234 Fax: +86 58497698 Email: alex@mbt-laser.com

    1. Designated Submission Correspondent
      Mr. Ray Wang

Beijing Believe-Med Technology Service Co., Ltd.

Rm.912, Building #15, XiYueHui, No.5, YiHe North Rd., FangShan District, Beijing, 102401, China

Tel: +86-18910677558 Fax: +86-10-56335780 Email: information@believe-med.com

{5}------------------------------------------------

    1. Identification of Proposed Device
      Trade Name: Diode Laser Hair Removal System Common Name: Powered Laser Surgical Instrument Model(s): MBT-Diode Laser

Regulatory Information: Classification Name: Powered Laser Surgical Instrument Classification: II; Product Code: GEX; Regulation Number: 21 CFR 878.4810; Review Panel: General & Plastic Surgery;

  • ર. Identification of Predicate Device(s) Predicate Device 510(k) Number: K211335 Product Name: Diode Laser Machine Manufacturer: Zhengzhou Bestview St Co., Ltd.
    Reference Device 510(k) Number: K200525 Product Name: Medical Diode Laser Hair Removal System Manufacturer:Weifang Mingliang Electronics CO., LTD.

  • Device Description: 6.
    Diode Laser Hair Removal System (Model: MBT-Diode Laser) is a surgical device, which is intended for hair removal, permanent hair reduction on all skin types (Fitzpatrick skin type I-VI). The Dermatological Diode Laser Systems utilize a semiconductor diode with invisible infrared radiation as a laser source to emit 808nm wavelength laser which is absorbed by melanin. The laser power is delivered to the treatment area via laser handle. The emission laser is activated by footswitch or handle button.

The Diode Laser Hair Removal System consists of the following major components

  • The main console unit that incorporates the main CPU board, power supply modules, laser a. power supply, laser device, cooling system and switching module
  • Handpiece b.
  • Footswitch C.
  • Indication For Use Statement: 7.

The Diode Laser Hair Removal System (Model: MBT-Diode Laser) is intended for hair removal, permanent hair reduction on all skin types (Fitzpatrick skin type I-VI), including tanned skin. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime.

{6}------------------------------------------------

8. Substantially Equivalent (SE) Comparison

Table 7-1 General Comparison
ItemProposed DevicePredicate DeviceK211335Reference DeviceK200525Remark
Device NameDiode Laser HairRemoval SystemDiode LaserMachineDiode LaserMachine/
ClassificationRegulation21 CFR 878.481021 CFR 878.481021 CFR 878.4810SAME
ClassificationPanelGeneral & PlasticSurgeryGeneral & PlasticSurgeryGeneral & PlasticSurgerySAME
ClassIIIIIISAME
Product CodeGEXGEXGEXSAME
Indication for useThe Diode Laser HairRemoval System is intendedfor hair removal, permanent hairreduction on all skintypes (Fitzpatrick skintype I-VI), includingtanned skin.Permanent hairreduction is definedas the long-term,stable reduction inthe number of hairsregrowing whenmeasured at 6, 9, and12 months after thecompletion of atreatment regime.The Diode LaserMachineModel:BM-100is intendedfor hair removal, permanent hairreduction on all skintypes (Fitzpatrick skintype I-VI), includingtanned skin.Permanent hairreduction is defined asthe long-term, stablereduction in thenumber of hairsregrowing whenmeasured at 6, 9, and12 months after thecompletion of atreatment regime.The Medical DiodeLaser HairRemoval System isused forpermanent reductionin hairregrowth defined as along term,stable reduction in thenumber ofhairs re-growingwhen measured at6, 9 and 12 monthsafter thecompletion of atreatment regimen.Use on all skin types( FitzpatrickI-VI), includingtanned skin.SAME

Table 7-1 General Comparison

Table 7-2 Performance Comparison

ITEMProposed DevicePredicate DeviceK211335Reference DeviceK200525Remark
Laser TypeDiode LaserDiode LaserDiode LaserSAME
LaserClassificationClass IVClass IVClass IVSAME
Laser808nm808nm808nmSAME

{7}------------------------------------------------

Wavelength
Spot Size15mm×15mm2.25cm²(15mm×15mm)1.44cm2(1.2 x 1.2 cm)SIMILAR
Fluence1-55.96J/cm²0-120J/cm²48 J/cm²Different
Frequency1-10Hz1-10Hz1-10HzSAME
Pulse Duration2-240ms10-400ms1-300msDifferent
Power Supply110 VAC/50Hz-60Hz220/110VAC/50Hz-60Hz220/110VAC/50Hz-60HzDifferent
Dimension650mm×580mm×1210mm112 cm × 42 cm ×60cm/Different
Weight68Kg63Kg/Different

Analysis :

Different - Fluence

The proposed device has different Fluence from the predicate device.

For the difference on fluence between the predicate and proposed device(s), The Fluence of Predicte Device K211335 is 0-120./cm², while the propose device is 55.96 J/cm². It is lower than 120 J/cm², the safety of the product is no problem. However, the effectiveness cannot be determined, so we selected Reference Device K200525 with the same intended use for Fluence comparison,The Fluence of the Reference Device is 48J/cm², which is similar to the Fluence of the proposed device, so the effectiveness of the product is not affected.And the proposed device has passed the IEC60601-1 test, IEC60601-1-2 test, IEC60601-2-22 test. IEC60825-1 test and performance test, the safety and performance of the product can be ensured.

Different - Pulse Duration

The proposed device has different pulse duration from the predicate device.

For the difference on pulse duration between the predicate and proposed device(s), we can see that the pulse duration range of proposed device is within the range of the predicate device. The pulse duration between the proposed device and the predicate device only with minor difference. And we think this minor difference will not affect the effectiveness and safety. And the proposed device has passed the IEC60601-1 test, IEC60601-1-2 test, IEC60601-2-22 test, IEC60825-1 test and performance test, the safety and performance of the product can be ensured.

Different - Power Supply

The power supply for the proposed device is different from the predicate device. However, electrical safety and EMC test has been conducted on the proposed device and the test result show that the device can work normally under this power supply. Therefore, this difference will not affect safety and effectiveness of the proposed device.

Different - Dimension, Weight

The proposed device is different in dimension and weight from the predicate device. By complying with IEC 60601-1, the mechanical performance of the proposed device is determined to be accepted, therefore,

{8}------------------------------------------------

this difference of dimension and weight have no effect the effectiveness and safety.

ItemProposed DevicePredicate DeviceK211335Remark
EMC, Electrical and Laser Safety
Electrical SafetyComply with IEC 60601-1, IEC60601-2-22Comply with IEC 60601-1, IEC60601-2-22SAME
EMCComply with IEC 60601-1-2Comply with IEC 60601-1-2SAME
Laser SafetyComply with IEC 60601-2-22, IEC60825Comply with IEC 60601-2-22,IEC 60825SAME
Patient Contact Materials and Biocompatibility
CytotoxicityNo CytotoxicityNo CytotoxicitySAME
SensitizationNo evidence of sensitizationNo evidence of sensitizationSAME
IrritationNo evidence of irritationNo evidence of irritationSAME

Table 7-3 Safety Comparison

Non-Clinical Test Conclusion 9.

Non clinical tests were conducted to verify that the proposed device met all design specifications as was Substantially Equivalent (SE) to the predicate device. The test results demonstrated that the proposed device complies with the following standards:

  • A IEC 60601-1 Edition 3.2 2020-08, Medical electrical equipment - Part 1: General requirements for basic safety and essential performance
  • A IEC 60601-1-2 Edition 4.1 2020-09, Medical Electrical Equipment-Part 1-2: General Requirements For Basic Safety And Essential Performance - Collateral Standard: Electromagnetic Compatibility-Requirements And Tests
  • A IEC 60825-1:2014, Safety of laser products - Part 1: Equipment classification, and requirements
  • IEC 60601-2-22: 2012 Medical electrical equipment - Part 2-22: Particular requirements for basic safety and essential performance of surgical, cosmetic, therapeutic and diagnostic laser equipment

  • ISO 10993-5: 2009 Biological Evaluation of Medical Devices -- Part 5: Tests For In Vitro Cytotoxicity

ISO 10993-10 Fourth edition 2021, Biological evaluation of medical devices - Part 10: Tests for skin A sensitization

ISO 10993-23 First edition 2021-01, Biological evaluation of medical devices - Part 23: Tests for irritation

    1. Clinical Test Conclusion
      No clinical study is included in this submission.

{9}------------------------------------------------

    1. Substantially Equivalent (SE) Conclusion
      Based on the nonclinical tests performed, the subject device is as safe, as effective, and performs as well as the legally marketed predicate device, Diode Laser Machine Model:BM-100 cleared under K211335.

§ 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology.

(a)
Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
(b)
Classification. (1) Class II.(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.